Lian Engelen
- Clinical Biochemistry top 0.5%
- Cardiology and Cardiovascular Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Physiology top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Coen D.A. StehouwerCasper G. SchalkwijkIsabel FerreiraPierre BoutouyrieJean L.J.M. ScheijenStéphane LaurentPieter C. DagnelieEgbert Clevers
- Topics
- Advanced Glycation End Products research (10 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers)Cardiovascular Health and Disease Prevention (5 papers)
- Cited by
- Clinical BiochemistryEndocrinology, Diabetes and MetabolismCardiology and Cardiovascular Medicine
- Partner nations
- NetherlandsDenmarkFrance
In The Last Decade
Lian Engelen
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Clinical Biochemistry 445
- Cardiology and Cardiovascular Medicine 381
- Endocrinology, Diabetes and Metabolism 304
- Physiology 202
- Pathology and Forensic Medicine 151
Countries citing papers authored by Lian Engelen
This map shows the geographic impact of Lian Engelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian Engelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian Engelen more than expected).
Fields of papers citing papers by Lian Engelen
This network shows the impact of papers produced by Lian Engelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian Engelen. The network helps show where Lian Engelen may publish in the future.
Co-authorship network of co-authors of Lian Engelen
This figure shows the co-authorship network connecting the top 25 collaborators of Lian Engelen. A scholar is included among the top collaborators of Lian Engelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lian Engelen. Lian Engelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 30 | |
| 3 | 46 | |
| 4 | 40 | |
| 5 | 46 | |
| 6 | 53 | |
| 7 | 256 | |
| 8 | 91 | |
| 9 | 5 | |
| 10 | 20 | |
| 11 | 101 | |
| 12 | Plasma advanced glycation end products are not associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies | 1 |
| 13 | 199 | |
| 14 | 97 | |
| 15 | 17 | |
| 16 | 72 | |
| 17 | 7 | |
| 18 | 1 | |
| 19 | 24 | |
| 20 | 21 |
About Lian Engelen
Lian Engelen is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cardiovascular Health and Disease Prevention (5 papers). The work is most often cited by research in Clinical Biochemistry (445 citations), Endocrinology, Diabetes and Metabolism (304 citations) and Cardiology and Cardiovascular Medicine (381 citations). Lian Engelen has collaborated with scholars based in Netherlands, Denmark and France. Frequent co-authors include Coen D.A. Stehouwer, Casper G. Schalkwijk, Isabel Ferreira, Pierre Boutouyrie, Jean L.J.M. Scheijen, Stéphane Laurent, Pieter C. Dagnelie, Egbert Clevers, Fred Brouns and Nish Chaturvedi. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Food Chemistry and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.